Revolution is developing drugs that target a molecular driver of cancers.
Read More from WSJ.com: US Business
Merck in Talks to Buy Revolution Medicines for Around $30 Billion
Sunday, January 11
Revolution is developing drugs that target a molecular driver of cancers.
Read More from WSJ.com: US Business